Year-over-year, this metric declined by 66.7%, from $600.00K to $200.00K.
An increase may indicate prior valuation inaccuracies or unexpected changes in acquired asset quality, while a decrease suggests stable initial valuation estimates.
Represents adjustments made to the fair value of assets acquired or liabilities assumed during the measurement period fo...
Common in companies with frequent M&A activity; peers typically report these as part of purchase price allocation adjustments.
iex_segment_health_science_technologies_measurement_period_adjustments| Q3 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.00M | $1.80M | $0.00 | $1.50M | $2.10M | $500.00K | $1.20M | $500.00K | $600.00K | $4.00M | $400.00K | $0.00 | $200.00K |
| QoQ Change | — | — | +80.0% | -100.0% | — | +40.0% | -76.2% | +140.0% | -58.3% | +20.0% | +566.7% | -90.0% | -100.0% | — |
| YoY Change | — | — | +80.0% | — | — | — | -72.2% | — | -66.7% | +20.0% | +233.3% | -20.0% | — | -66.7% |